Table 1 Baseline characteristics of the participants in the SAAR and control groups1
Characteristics | SAAR (n = 31) | Controls (n = 28) | ||
|---|---|---|---|---|
Males, n (%) | 8 (25.8) | 8 (28.6) | ||
| Â | Mean (SD) | Median (IQR) | Mean (SD) | Median (IQR) |
Age, y | 33.2 (5.86) | 32 (29.5, 37.0) | 34.4 (6.26) | 34 (29.5, 38.8) |
Body weight, kg | 94.4 (10.7) | 93.2 (86.6, 102) | 88.7 (9.22) | 88.6 (82.0, 95.7) |
Body mass index, kg/m2 | 31.4 (2.12) | 31.2 (29.5, 33.2) | 30.8 (2.20) | 30.3 (29.0, 32.4) |
Waist-to-hip ratio | 0.85 (0.08) | 0.84 (0.79, 0.90) | 0.86 (0.08) | 0.84 (0.79, 0.92) |
Percent body fat, % | 42.0 (6.76) | 44.0 (37.8, 47.3) | 42.4 (5.80) | 44.1 (39.2, 46.4) |
Systolic blood pressure, mm/Hg | 120 (10.9) | 119 (111, 128) | 119 (10.7) | 118 (112, 125) |
Diastolic blood pressure, mm/Hg | 69.1 (7.57) | 70.0 (64.0, 73.0) | 70.0 (8.50) | 66.7 (63.6, 76.1) |
Apolipoprotein B, g/L | 0.81 (0.20) | 0.80 (0.65, 0.90) | 0.91 (0.24) | 0.90 (0.8, 1.00) |
Apolipoprotein A1, g/L | 1.49 (0.24) | 1.50 (1.3, 1.6) | 1.47 (0.26) | 1.40 (1.30, 1.55) |
LDL, mmol/L | 2.81 (0.69) | 2.80 (2.15, 3.35) | 3.11 (0.71) | 3.20 (2.65, 3.50) |
HDL, mmol/L | 1.40 (0.36) | 1.30 (1.10, 1.65) | 1.39 (0.38) | 1.3 (1.15, 1.50) |
Total cholesterol, mmol/L | 4.66 (0.75) | 4.90 (4.00, 5.15) | 4.93 (0.83) | 5.00 (4.35, 5.35) |
Triglycerides, mmol/L | 1.15 (0.55) | 1.00 (0.7, 1.3) | 1.07 (0.42) | 1.00 (0.8, 1.35) |
Glucose, mmol/L | 5.16 (0.41) | 5.20 (4.90, 5.45) | 5.31 (0.50) | 5.4 (5.05, 5.60) |
Insulin, pmol/L | 81.0 (47.0) | 77.0 (43.5, 96.0) | 75.5 (39.9) | 66.0 (47.5, 99.5) |
ASAT, U/L | 24.3 (8.83) | 24.0 (19.0, 26.0) | 22.6 (6.93) | 20.0 (18.0, 25.5) |
ALAT, U/L | 25.4 (9.64) | 24.0 (20.0, 27.0) | 27.9 (17.3) | 22.0 (17.5, 31.0) |
Creatinine, µmol/L | 66.4 (11.4) | 67.0 (56.5, 74.5) | 69.0 (11.9) | 72.0 (60.5, 76.5) |
Resting metabolic rate, kcal/d | 2016 (279) | 2016 (1814, 2131) | 1944 (288) | 1944 (1728, 2145) |
Respiratory quotient | 0.79 (0.05) | 0.79 (0.76, 0.83) | 0.79 (0.03) | 0.79 (0.77, 0.81) |